Hideki Tsujimura

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Generating Patient Documents from Electronic Health Records Using Generative Artificial Intelligence: A Feasibility Study in a Japanese Cancer Center.

Generating Patient Documents from Electronic Health Records Using Generative Artificial Intelligence: A Feasibility Study in a Japanese Cancer Center.

Journal: Applied clinical informatics
Published: July 20, 2026

Efficacy of polatuzumab vedotin versus conventional chemotherapy in relapsed or refractory diffuse large B-cell lymphoma.

Efficacy of polatuzumab vedotin versus conventional chemotherapy in relapsed or refractory diffuse large B-cell lymphoma.

Journal: International journal of hematology
Published: April 21, 2025

Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).

Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).

Journal: Cancer chemotherapy and pharmacology
Published: December 21, 2024

Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601.

Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601.

Journal: Annals of hematology
Published: July 16, 2023

Double-hit follicular lymphoma diagnosed due to central nervous system symptoms.

Double-hit follicular lymphoma diagnosed due to central nervous system symptoms.

Journal: Annals of hematology
Published: December 14, 2022

Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).

Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).

Journal: Cancer science
Published: April 03, 2022

Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.

Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.

Journal: International journal of hematology
Published: October 22, 2021

HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).

HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).

Journal: Cancer science
Published: May 26, 2021

Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort.

Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort.

Journal: British journal of haematology
Published: March 22, 2021

Synchronous early-stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report.

Synchronous early-stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report.

Journal: Molecular and clinical oncology
Published: February 18, 2021

Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.

Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.

Journal: Cancer science
Published: November 24, 2020

Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.

Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.

Journal: Hematological oncology
Published: May 31, 2020
Showing 1-12 of 29

Last Updated: 09/26/2026